Skip to main content

Table 1 Characteristics of the patients (N = 60)

From: Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy

Variable N %
Ages, yrs, mean ± SD (IQR) 44.1 ± 13.8 (33–54)
  ≥ 45 29 48.3
  ≥ 55 14 23.3
Sex, male/female 18/42 30.0/70.0
BMI 23.1 ± 3.7  
NG 24 40.0
HD 8 13.3
Hypertension 5 8.3
Diabetes 3 5.0
Hyperthyroidism 5 8.3
Hypothyroidism 0 0
Tumor size (primary), mm
 Mean ± SD (IQR) 21.7 ± 14.3 (10.75–22.25)  
  > 40 mm 7 11.7
Multifocality (primary) 11 18.3
Bilaterality (primary) 8 13.3
TgAb positive (> 115U/mL) 8 13.3
TNM stage (primary)
 Tx/T1/T2/T3/T4 8/11/6/16/19 13.3/18.3/10.0/26.7/31.7
 Nx/N0/N1a/N1b 0/11/12/37 0/18.3/20.0/61.7
 Mx/M0/M1 1/59/0 1.7/98.3/0
Surgical strategy
 iCND/bCND 4/15 6.7/25.0
 iCND + iLND 7 11.7
 bCND + iLND 24 40.0
 bCND + bLND 10 16.7
Harvested LNs 33.0 ± 20.8  
Metastatic LNs 8.5 ± 8.2  
The ratio of metastatic LNs % 29.5 ± 23.1  
RAI Administration 49 81.7
Central LNs recurrence 19 31.7
Lateral LNs recurrence 36 60.0
Central & lateral LNs recurrence 5 8.3
Diameters of recurrent LNs, mm, Mean ± SD (IQR) 18.7 ± 12.9 (10.75–22.00)  
Extranodal extension 20 33.3
  1. BMI Body Mass Index, HD Hashimoto's disease, NG nodular goiter, iCND ipsilateral central neck dissection, bCND bilateral central neck dissection, iLND ipsilateral lateral neck dissection, bLND bilateral lateral neck dissection, LN lymph node